2024-03-29T09:19:13Zhttp://repisalud.isciii.es/oai/requestoai:repisalud.isciii.es:20.500.12105/103582022-11-07T11:48:53Zcom_20.500.12105_2152com_20.500.12105_2051com_20.500.12105_2144col_20.500.12105_2153
Repisalud
author
González, María Isabel
author
Martin-Duque, Pilar
author
Desco, Manuel
author
Salinas, Beatriz
funder
Instituto de Salud Carlos III
funder
Ministerio de Ciencia, Innovación y Universidades (España)
funder
Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
funder
Comunidad de Madrid (España)
funder
Fundación ProCNIC
2020-06-11T13:48:52Z
2020-06-11T13:48:52Z
2020-05-30
Nanomaterials (Basel). 2020; 10(6):e1062
2079-4991
http://hdl.handle.net/20.500.12105/10358
32486215
10.3390/nano10061062
Nanomaterials (Basel, Switzerland)
Over the last decade, exosomes from diverse biological sources have been proposed as new natural platforms in drug delivery. Translation of these nanometric tools to clinical practice requires deep knowledge of their pharmacokinetic properties and biodistribution. The pharmacokinetic properties of exosomes are sometimes evaluated using biochemical and histological techniques that are considerably invasive. As an alternative, we present radiochemical labeling of milk-derived exosomes based on reduced 99mTc (IV) without modifying biological and physicochemical properties. This approach enables longitudinal tracking of natural exosomes by non-invasive single photon emission computed tomography (SPECT) imaging and the evaluation of their pharmacokinetic properties according to the route of administration.
eng
Radioactive Labeling of Milk-Derived Exosomes with 99mTc and In Vivo Tracking by SPECT Imaging.
journal article
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
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/1/RadioactiveLabelingMilkDerived_2020.pdf
File
MD5
6d54977b7a89d3a38799fc7099b59e03
810782
application/pdf
RadioactiveLabelingMilkDerived_2020.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/2/RadioactiveLabelingMilkDerived_2020_Figure1_2D_3_4_5%20available%20data.pdf
File
MD5
bff22443a1d75624807e3a1a809ef306
399708
application/pdf
RadioactiveLabelingMilkDerived_2020_Figure1_2D_3_4_5 available data.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/3/RadioactiveLabelingMilkDerived_2020_Figure%202C_HPLC%20available%20data.pdf
File
MD5
737f97b4b982c695434bd1c548d7577a
245987
application/pdf
RadioactiveLabelingMilkDerived_2020_Figure 2C_HPLC available data.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/4/RadioactiveLabelingMilkDerived_2020_Figure%202B_DLS%20available%20data.pdf
File
MD5
fb9920a9eecf625b39bbe786bd4abf12
82445
application/pdf
RadioactiveLabelingMilkDerived_2020_Figure 2B_DLS available data.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/15/RadioactiveLabelingMilkDerived_2020.pdf.txt
File
MD5
12ce77722d5455282b1db9bfb56ce440
49969
text/plain
RadioactiveLabelingMilkDerived_2020.pdf.txt
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/17/RadioactiveLabelingMilkDerived_2020_Figure1_2D_3_4_5%20available%20data.pdf.txt
File
MD5
f76bd86024034b94d4de92f0111fc981
4396
text/plain
RadioactiveLabelingMilkDerived_2020_Figure1_2D_3_4_5 available data.pdf.txt
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/19/RadioactiveLabelingMilkDerived_2020_Figure%202C_HPLC%20available%20data.pdf.txt
File
MD5
c47254ea5d3124caa69f3574674208b3
177417
text/plain
RadioactiveLabelingMilkDerived_2020_Figure 2C_HPLC available data.pdf.txt
URL
https://repisalud.isciii.es/bitstream/20.500.12105/10358/21/RadioactiveLabelingMilkDerived_2020_Figure%202B_DLS%20available%20data.pdf.txt
File
MD5
7f46091dba3f47eafcfcb2d42912dc17
3113
text/plain
RadioactiveLabelingMilkDerived_2020_Figure 2B_DLS available data.pdf.txt